FWBI logo

First Wave BioPharma, Inc. Common Stock


FWBI: First Wave BioPharma Inc is a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal diseases. It is advancing a therapeutic development pipeline populated with multiple clinical-stage programs built around its two proprietary technologies-niclosamide, an oral small molecule with anti-viral and anti-inflammatory properties, and the biologic adrulipase, a recombinant lipase enzyme designed to enable the digestion of fats and other nutrients.


Show FWBI Financials

Consumer Interest
SEC Filings

Recent trades of FWBI by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quarterly net insider trading by FWBI's directors and management

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

Quiver Logo

No new patents for this ticker

U.S. Patents Dashboard
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard

Number of mentions of FWBI in WallStreetBets Daily Discussion


Recent insights relating to FWBI

CNBC Recommendations

Recent picks made for FWBI stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in FWBI

Corporate Flights

Flights by private jets registered to FWBI